Article Text

Download PDFPDF

Foot temperature monitoring at home reduced foot complications in high risk patients with diabetes
  1. Dereck Hunt, MD, MSc, FRCPC
  1. McMaster University
 Hamilton, Ontario, Canada

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

 Q What is the effectiveness of at home, infrared foot temperature monitoring for preventing foot complications in high risk patients with diabetes?

    Clinical impact ratings Internal Medicine ★★★★★★☆ Endocrine ★★★★★★☆


    Embedded ImageDesign:

    randomised controlled trial.

    Embedded ImageAllocation:


    Embedded ImageBlinding:


    Embedded ImageFollow up period:

    6 months.

    Embedded ImageSetting:

    high risk diabetes foot clinics at the University of Texas Health Science Center, San Antonio, Texas.

    Embedded ImagePatients:

    85 patients 18–80 years of age (mean age 55 y, 51% men) who had diabetes (World Health Organization criteria) and were at high risk of developing diabetic foot ulcerations (International Working Group on the Diabetic Foot risk group 2 or 3—ie, history of foot ulceration or lower extremity amputation, or peripheral sensory neuropathy with loss of protective sensation or foot deformity such as hallux valgus or claw toes). Exclusion criteria: open ulcers or open amputation sites, active Charcot arthropathy, peripheral vascular disease, active foot infection, dementia, impaired cognitive function, or history of drug or alcohol use in the previous year.

    Embedded ImageIntervention:

    enhanced (n = 41) or standard therapy (n = 44). All patients received standard care, which included therapeutic footwear, education, and foot evaluation by a podiatrist every 10–12 weeks. Patients in the enhanced therapy group also used a hand held, infrared skin thermometer (TempTouch, Xilas Medica, San Antonio, Texas) to measure the temperature of 6 predetermined sites on the sole of the foot (first, third, and fifth metatarsal head; great toe; central mid-foot; and heel) in the morning and evening; higher temperatures were considered to indicate ongoing inflammation. If the temperature of corresponding sites on the left and right foot differed by >2.2°C (4°F), patients were advised to contact a nurse case manager and to reduce the number of steps taken in the following days until the temperature difference was <2.2°C.

    Embedded ImageOutcomes:

    diabetic foot complications (incident foot ulcers, infections, Charcot fractures, and amputations).

    Embedded ImagePatient follow up:

    100% (intention to treat analysis).


    Patients in the enhanced therapy group had fewer diabetic foot complications overall and fewer ulcers (table). The groups did not differ for Charcot fractures (0 v 2), infections (0 v 2 [later required amputation]), or local foot amputations (0 v 2).

    Enhanced therapy with at home, infrared foot temperature monitoring v standard therapy for preventing foot complications in high risk patients with diabetes without peripheral vascular disease*


    In high risk patients with diabetes, at home, infrared foot temperature monitoring reduced foot complications compared with standard care.

    A modified version of this abstract appears in Evidence-Based Nursing.


    Foot complications, including ulceration and amputation, are all too common in people with diabetes mellitus. Given this, development and evaluation of new approaches to prevent lower extremity complications are urgently needed.

    The study by Lavery et al evaluates a unique approach for preventing foot ulceration by using a hand held, infrared skin thermometer to detect increases in foot temperature. The strengths of the study include its randomised design and high level of follow up. Unfortunately, the study does have some weaknesses. The study was not blinded, and the authors did not provide an operational definition for some of the outcomes (eg, foot ulceration or Charcot fracture).

    The authors also did not report the rate at which intervention patients contacted the nurse case manager to seek advice. Thus, it is difficult to assess the relative contributions of the new technology and having access to an additional healthcare provider.

    This is an exciting pilot study in an area urgently in need of ongoing research. It would be premature, however, to conclude that all patients with diabetes who are at high risk of foot ulceration should now do home monitoring of foot skin temperatures. Instead, this trial lays the groundwork for future studies.

    In the meantime, we should continue to be vigilant in identifying patients at high risk of lower extremity complications and ensuring that they receive appropriate foot care education.1


    View Abstract


    • * See glossary.

    • Information provided by author.

    • For correspondence: Dr L A Lavery, Scott and White Hospital, Temple, TX, USA.

    • Source of funding: National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases.